Diabetes Prevention Program (DPP) Research Group
Molecular Metabolism 45:101165
Side Effect Profile Both medications have similar side effect profiles, with gastrointestinal issues being the most common: Nausea Diarrhea Vomiting Constipation Abdominal pain While the incidence of side effects is generally similar between the two medications, some studies suggest that tirzepatide may have a slightly higher rate of gastrointestinal side effects, particularly at higher doses
It lowers the amount of glucagon
Theres no known mechanism where NAD+ boosters down-regulate your bodys ability to make its own NAD+
The dual mechanism of tirzepatide acts on both the GLP-1 and GIP receptors, presenting a multifaceted approach to a complex health issue, while the insights on dosages, administration, and safety profiles have equipped both patients and healthcare providers with the knowledge to make informed decisions